Effectiveness of Centers for Disease Control and Prevention recommendations for outcomes of acute otitis media

Pediatrics

Volumn 117, Issue 4, 2006, Pages 1009-1017

  Bauchner, Howard ^a,c   Marchant, Colin D ^a   Bisbee, Alice ^b   Heeren, Timothy ^b   Wang, Bingxia ^b   McCabe, Megan ^d   Pelton, Stephen ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d NONE

Author keywords

Acute otitis media; Centers for Disease Control and Prevention; Recommendations; Treatment

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN;

ACUTE OTITIS MEDIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEALTH CARE QUALITY; HUMAN; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; ACUTE DISEASE; CHILD; DAY CARE; MULTICENTER STUDY; OTITIS MEDIA; PRACTICE GUIDELINE; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CHILD DAY CARE CENTERS; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT; MALE; OTITIS MEDIA; PRACTICE GUIDELINES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 33646373208     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2172     Document Type: Article

References (24)

1. Pichichero ME. Acute otitis media, II: treatment in an era of increasing antibiotic resistance. Am Fam Physician. 2002;6:2410-2416
2. Dowell SF. Acute otitis media caused by resistant pneumococci. Am Fam Physician. 2000;61:318-323
3. Paradise JL. A 15-month-old child with recurrent otitis media. JAMA. 2002;288:2589-2598
4. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589-595
5. Casey JR, Pichichero M. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23:824-828
6. Jacobs MR. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J. 2003;22(suppl):S109-S119
7. Uhari M, Mantysaari K, Niemela M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis. 1996;22:1079-1083
8. Froom J, Culpepper L, Green LA, et al. A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit: report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN). J Am Board Fam Pract. 2001;14:406-417
9. Dowell SF, Butler JC, Giebin GS, et al. Acute otitis media: management and surveillance in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9
10. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-259
11. Kaplan SL, Mason EO. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann. 2002;31:250-260
12. Mazmanian PE, David DA. Continuing medical education and the physician as a learner: guide to the evidence. JAMA. 2002;288:1057-1060
13. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705
14. Adler M, McDonald PJ, Trostmann U, Keyserling C, Tack K. Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. Pediatr Infect Dis J. 2000;19(suppl):S166-S170
15. Block ST, Hedrick JA, Tyler RD, et al. Microbiology of acute otitis media recently treated with aminopenicillins. Pediatr Infect Dis J. 2001;20:1017-1021
16. Marchant CD, Carline SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: "the Pollyanna Phenomenon." J Pediatr. 1992;120:72-77
17. Carlin SA, Marchant CD, Shurin PA, et al. Host factors and early therapeutic response in acute otitis media: does symptomatic response correlate with bacterial outcome? J Pediatr. 1991;118:178-183
18. Dagan R, Leibovitz E, Greenberg D, et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17:776-782
19. Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003;112:862-869
20. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics. 1991;87:466-474
21. Dagan R, Leibovitz E, Cheletz G, et al. Antibiotic treatment in acute otitis media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment. J Infect Dis. 2001;183:880-886
22. Leibovitz E, Greenber D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J. 2003;22:209-215
23. Quach C, Collet JP, Lelorier J. Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study. Pharmacoepidemiol Drug Saf. 2005;14:163-170
24. Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA. 2003;290:1633-1640